Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0000921895-26-000502·BIOTECHNOLOGY VALUE FUND L P
Schedule 13G ownership disclosure
Sutro Biopharma, Inc.
Common Stock, $0.001 par value · CUSIP: 869367201
Event date: 2026-02-10
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- BIOTECHNOLOGY VALUE FUND L P
Shares: 668,693.00 · Class: 4.1%
- BVF I GP LLC
Shares: 668,693.00 · Class: 4.1%
- BIOTECHNOLOGY VALUE FUND II LP
Shares: 488,916.00 · Class: 3.0%
- BVF II GP LLC
Shares: 488,916.00 · Class: 3.0%
- Biotechnology Value Trading Fund OS LP
Shares: 75,359.00 · Class: 0.5%
- BVF Partners OS Ltd.
Shares: 75,359.00 · Class: 0.5%
- BVF GP HOLDINGS LLC
Shares: 1,157,609.00 · Class: 7.0%
- BVF PARTNERS L P/IL
Shares: 1,251,788.00 · Class: 7.6%
- BVF INC/IL
Shares: 1,251,788.00 · Class: 7.6%
- LAMPERT MARK N
Shares: 1,251,788.00 · Class: 7.6%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000921895-26-000502
- Form type
- SCHEDULE 13G
- Filer
- BIOTECHNOLOGY VALUE FUND L P
- CIK
- CIK 918923
- Filed
- Feb 18, 2026
- Reporting period
- Feb 10, 2026
- Description
- Schedule 13G beneficial ownership